Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.370
+0.170 (7.73%)
At close: Dec 20, 2024, 4:00 PM
2.380
+0.010 (0.42%)
After-hours: Dec 20, 2024, 6:43 PM EST
Nkarta Employees
Nkarta had 150 employees as of December 31, 2023. The number of employees decreased by 13 or -7.98% compared to the previous year.
Employees
150
Change (1Y)
-13
Growth (1Y)
-7.98%
Revenue / Employee
n/a
Profits / Employee
-$737,393
Market Cap
167.25M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 150 | -13 | -7.98% |
Dec 31, 2022 | 163 | 27 | 19.85% |
Dec 31, 2021 | 136 | 41 | 43.16% |
Dec 31, 2020 | 95 | - | - |
Related Stocks
Company Name | Employees |
---|---|
2seventy bio | 274 |
Lyell Immunopharma | 224 |
Caribou Biosciences | 158 |
TScan Therapeutics | 154 |
Solid Biosciences | 88 |
Elutia | 54 |
Fennec Pharmaceuticals | 29 |
Greenwich LifeSciences | 7 |
NKTX News
- 16 days ago - Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2 - GlobeNewsWire
- 25 days ago - Nkarta to Participate in an Upcoming Investor Conference - GlobeNewsWire
- 6 weeks ago - Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights - GlobeNewsWire
- 2 months ago - Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month - Benzinga
- 3 months ago - Nkarta to Participate in Upcoming Investor Conference - GlobeNewsWire
- 4 months ago - Nkarta: NK Cell Therapy Biotech With Good Standing Targeting R/R NHL Patients - Seeking Alpha
- 4 months ago - Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights - GlobeNewsWire
- 4 months ago - Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights - GlobeNewsWire